Literature DB >> 20633231

Delineating the regions of human transferrin involved in interactions with transferrin binding protein B from Neisseria meningitidis.

Jessmi M L Ling1, Collin H Shima, David C Schriemer, Anthony B Schryvers.   

Abstract

Pathogenic bacteria in the Neisseriaceae possess a surface receptor mediating iron acquisition from human transferrin (hTf) that consists of a transmembrane iron transporter (TbpA) and a surface-exposed lipoprotein (TbpB). In this study, we used hydrogen/deuterium exchange coupled to mass spectrometry (H/DX-MS) to elucidate the effects on hTf by interaction with TbpB or derivatives of TbpB. An overall conserved interaction was observed between hTf and full-length or N-lobe TbpB from Neisseria meningitidis strains B16B6 or M982 that represent two distinct subtypes of TbpB. Changes were observed exclusively in the C-lobe of hTf and were caused by the interaction with the N-lobe of TbpB. Regions localized to the 'lip' of the C1 and C2 domains that flank the interdomain cleft represent sites of direct contact with TbpB whereas the peptides within the interdomain cleft that encompass iron binding ligands are inaccessible in the closed (holo) conformation. Although substantial domain separation upon binding TbpB cannot be excluded by the H/DX-MS data, the preferred model of interaction involves binding hTf C-lobe in the closed conformation. Alternate explanations are provided for the substantial protection from deuteration of the peptides encompassing iron binding ligands within the interdomain cleft but cannot be differentiated by the H/DX-MS data.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20633231     DOI: 10.1111/j.1365-2958.2010.07289.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  8 in total

1.  Anchor peptide of transferrin-binding protein B is required for interaction with transferrin-binding protein A.

Authors:  Xue Yang; Rong-hua Yu; Charles Calmettes; Trevor F Moraes; Anthony B Schryvers
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

2.  Conserved interaction between transferrin and transferrin-binding proteins from porcine pathogens.

Authors:  Leslie P Silva; Ronghua Yu; Charles Calmettes; Xue Yang; Trevor F Moraes; Anthony B Schryvers; David C Schriemer
Journal:  J Biol Chem       Date:  2011-04-12       Impact factor: 5.157

3.  Tag and Capture Flow Hydrogen Exchange Mass Spectrometry with a Fluorous-Immobilized Probe.

Authors:  Sean R Marcsisin; Cary Liptak; Jason Marineau; James E Bradner; John R Engen
Journal:  Anal Chem       Date:  2015-05-29       Impact factor: 6.986

4.  Structural variations within the transferrin binding site on transferrin-binding protein B, TbpB.

Authors:  Charles Calmettes; Rong-hua Yu; Leslie P Silva; Dave Curran; David C Schriemer; Anthony B Schryvers; Trevor F Moraes
Journal:  J Biol Chem       Date:  2011-02-05       Impact factor: 5.157

5.  Hydrogen/deuterium exchange mass spectrometry and site-directed disulfide cross-linking suggest an important dynamic interface between the two lysostaphin domains.

Authors:  Hai-Rong Lu; Mei-Gang Gu; Qiang Huang; Jin-jiang Huang; Wan-Ying Lu; Hong Lu; Qing-Shan Huang
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

6.  Platform dependencies in bottom-up hydrogen/deuterium exchange mass spectrometry.

Authors:  Kyle M Burns; Martial Rey; Charles A H Baker; David C Schriemer
Journal:  Mol Cell Proteomics       Date:  2012-11-28       Impact factor: 5.911

7.  The structural basis of transferrin sequestration by transferrin-binding protein B.

Authors:  Charles Calmettes; Joenel Alcantara; Rong-Hua Yu; Anthony B Schryvers; Trevor F Moraes
Journal:  Nat Struct Mol Biol       Date:  2012-02-19       Impact factor: 15.369

8.  Lactoferrin binding protein B - a bi-functional bacterial receptor protein.

Authors:  Nicholas K H Ostan; Rong-Hua Yu; Dixon Ng; Christine Chieh-Lin Lai; Anastassia K Pogoutse; Vladimir Sarpe; Morgan Hepburn; Joey Sheff; Shaunak Raval; David C Schriemer; Trevor F Moraes; Anthony B Schryvers
Journal:  PLoS Pathog       Date:  2017-03-03       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.